Structure-activity relationship of triaryl propionic acid analogues on the human EP3 prostanoid receptor.

[1]  D. Denis,et al.  Structure–Activity Relationship of Biaryl Acylsulfonamide Analogues on the Human EP3 Prostanoid Receptor , 2002 .

[2]  S. Narumiya,et al.  Characterization of EP receptor subtypes responsible for prostaglandin E2‐induced pain responses by use of EP1 and EP3 receptor knockout mice , 2001, British journal of pharmacology.

[3]  G. FitzGerald,et al.  Activation of the murine EP3 receptor for PGE2 inhibits cAMP production and promotes platelet aggregation. , 2001, The Journal of clinical investigation.

[4]  Y. Sugimoto,et al.  Roles of prostanoids revealed from studies using mice lacking specific prostanoid receptors. , 2000, Japanese journal of pharmacology.

[5]  S. Okamoto,et al.  Synthesis and structure-activity relationships of a new class of selective EP3 receptor agonist, 13,14-didehydro-16-phenoxy analogues of prostaglandin E1. , 2000, Bioorganic & medicinal chemistry.

[6]  Y. Boie,et al.  The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. , 2000, Biochimica et biophysica acta.

[7]  S. Narumiya,et al.  Impaired duodenal bicarbonate secretion and mucosal integrity in mice lacking prostaglandin E-receptor subtype EP(3). , 1999, Gastroenterology.

[8]  Atsushi Ichikawa,et al.  Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3 , 1998, Nature.

[9]  S. Narumiya,et al.  Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells , 1997, British journal of pharmacology.